Sea Mild Biotechnology Co., Ltd. (TPEX:7516)

Sea Mild Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	64.62	89.2	82.94	46.63	40.58	38.95
Cash & Short-Term Investments	64.62	89.2	82.94	46.63	40.58	38.95
Cash Growth	1.21%	7.54%	77.89%	14.91%	4.19%	-25.20%
Accounts Receivable	94.9	79.62	63.62	58.26	57.67	50.53
Receivables	94.9	79.62	63.62	58.26	57.67	50.53
Inventory	93.58	68.19	58.01	28.81	16.77	21.14
Prepaid Expenses	6.61	10.47	3.1	7.16	1.38	2.47
Other Current Assets	10.63	10.55	8.74	9.99	6.99	0.03
Total Current Assets	270.32	258.03	216.42	150.84	123.39	113.11
Property, Plant & Equipment	58.37	58.97	24.9	23.2	27.29	43.23
Other Intangible Assets	-	-	-	0.03	0.31	0.71
Long-Term Deferred Tax Assets	0.96	0.96	0.91	1.86	1.81	1.7
Other Long-Term Assets	11.93	7.97	13.89	14.44	4.88	9.5
Total Assets	341.59	325.92	256.11	190.36	157.69	168.23

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	79	73.61	65.24	50.32	46.48	37.37
Accrued Expenses	12.05	12.39	14.37	8.46	7.35	8.11
Short-Term Debt	60	50	30	25	3.05	-
Current Portion of Long-Term Debt	3.93	8.88	16.67	-	-	-
Current Portion of Leases	13.35	13.05	6.83	12.91	10.65	7.84
Current Unearned Revenue	0.37	0.58	0.61	0.33	0.65	1.38
Other Current Liabilities	29.53	19.27	16.06	16.6	13.36	10.4
Total Current Liabilities	198.23	177.78	149.78	113.61	81.55	65.1
Long-Term Debt	11.61	13.58	3.33	-	-	-
Long-Term Leases	18.02	23.93	0.59	6.34	11.65	17.32
Long-Term Deferred Tax Liabilities	0	0	-	0	0.02	-
Other Long-Term Liabilities	0.01	0.01	0.01	-	-	-
Total Liabilities	227.87	215.31	153.71	119.96	93.21	82.41

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	193.09	193.09	193.09	193.09	193.09	193.09
Retained Earnings	-78.87	-81.86	-90.7	-122.68	-128.87	-107.49
Comprehensive Income & Other	-0.5	-0.62	-	-	0.27	0.22
Total Common Equity	113.72	110.61	102.39	70.41	64.48	85.82
Shareholders' Equity	113.72	110.61	102.39	70.41	64.48	85.82
Total Liabilities & Equity	341.59	325.92	256.11	190.36	157.69	168.23

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	106.9	109.44	57.42	44.25	25.35	25.16
Net Cash (Debt)	-42.28	-20.24	25.52	2.38	15.23	13.79
Net Cash Growth	-	-	974.65%	-84.40%	10.45%	-23.54%
Net Cash Per Share	-2.19	-1.05	1.32	0.12	0.79	0.71
Filing Date Shares Outstanding	19.31	19.31	19.31	19.31	19.31	19.31
Total Common Shares Outstanding	19.31	19.31	19.31	19.31	19.31	19.31
Working Capital	72.1	80.24	66.64	37.23	41.85	48.01
Book Value Per Share	5.89	5.73	5.30	3.65	3.34	4.44
Tangible Book Value	113.72	110.61	102.39	70.37	64.17	85.11
Tangible Book Value Per Share	5.89	5.73	5.30	3.64	3.32	4.41
Machinery	96.9	92.43	78.6	67.32	66.07	67.04

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 7, 2026

Data Sources Report a data error